Common ADHD drug tested as potential relief for debilitating MS fatigue

NCT ID NCT02286557

Summary

This study tested whether methylphenidate, a stimulant medication commonly used for ADHD, could help reduce the severe cognitive fatigue experienced by most people with Multiple Sclerosis (MS). In this trial, 36 adults with MS tried both the drug and a placebo, with neither they nor the researchers knowing which they received at the time. The goal was to provide solid evidence for doctors on whether this already-approved medication could be a helpful treatment for this common and disabling MS symptom.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FATIGUE IN MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Kessler Foundation

    East Hanover, New Jersey, 07936, United States

Conditions

Explore the condition pages connected to this study.